Connect with us

Health & Fitness

COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety

Health & Fitness

Telehealth can be a safe technique in high-risk pregnancies, study shows

Health & Fitness

How healthcare orgs can protect their supply chain from cyber risks

Health & Fitness

Diabetes Doubles Risk of Death From COVID-19; East-West Divide?

Health & Fitness

Hormonal Therapy Produces Best Cryptorchidism Outcomes

Health & Fitness

An Olympian Tried to See How Much Weight He Could Gain in Just 30 Days

Health & Fitness

FDA Approves Medtronic's Onyx Frontier Drug-Eluting Stent

Health & Fitness

30 Days of the 'Baby Monkey' Workout Shredded This Guy's Abs

Health & Fitness

Orlando Bloom Looks Ripped While Showing Off His Chest Tattoos

Health & Fitness

Watch This Bodybuilder Try to Get Through a Day Following Elon Musk's Routine

Health & Fitness

COVID-19 Anticoagulation Trials ‘Paused’ for Futility, Safety

The REMAP-CAP, ACTIV-4 and ATTACC studies evaluating increased levels of anticoagulation in hospitalized COVID-19 patients have paused enrollment of patients treated in the ICU, the NHLBI confirms. Medscape Medical News

Published

1 year ago

on

COVID-19 Anticoagulation Trials ‘Paused’ for Futility, Safety

The REMAP-CAP, ACTIV-4 and ATTACC studies evaluating increased levels of anticoagulation in hospitalized COVID-19 patients have paused enrollment of patients treated in the ICU, the NHLBI confirms. Medscape Medical News
Read More

Related Topics:
Continue Reading